Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on influenza diagnostic market provides an in-depth analysis of segments and sub-segments in global as well as regional influenza diagnostic market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional influenza diagnostic market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global influenza diagnostic market. According to the report the global influenza diagnostic market is projected to grow at a CAGR of 7.9% over the forecast period of 2018-2024.
Market Insights
Influenza is most commonly known as the flu. It is an infectious disease caused by the influenza virus. There are three types of influenza viruses that affect people, called seasonal influenza, pandemic influenza and zoonotic or variant influenza. Usually, the virus is spread through the air from coughs or sneezing. This is believed to occur mostly over relatively short distances. It can also be spread by touching surfaces contaminated by the virus and then touching the mouth or eyes. The most common symptoms include high fever, runny nose, sore throat, muscle pains, headache, coughing, and tired feeling. These symptoms typically begin two days after exposure to the virus and most last less than a week.
Seasonal influenza viruses circulate and cause disease in humans every year. In temperate climates, the disease tends to occur seasonally in the winter months, spreading from person-to-person through sneezing, coughing, or touching contaminated surfaces. Seasonal influenza viruses evolve continuously, which means that people can get infected multiple times throughout their lives. Therefore the components of seasonal influenza vaccines should be reviewed frequently and updated periodically to ensure the continued effectiveness of the vaccines. Thus increasing prevalence of influenza and rising demand for faster diagnosis and control of influenza to drive the market growth. In addition growth in research funding for Influenza diagnostics to augment market growth. However, increasing the price of novel influenza diagnostic techniques hinder market growth. Advancements in genomic and proteomic techniques can create lucrative opportunities for market growth.
Among the geographies, North America held the largest market share in diagnostic influenza market in 2017, owing to increasing health awareness among the population, government initiatives to control the disease rates and development of novel influenza diagnostic techniques. Asia Pacific is expected to grow at the fastest CAGR during the forecast period, owing to rising healthcare infrastructure, a higher rate of the population which in turn, increases the chances of people getting affected with influenza.
Segment Covered
The report on global influenza diagnostic market covers segments such as test type and end-user. On the basis of test type, the global influenza diagnostic market is categorized into rapid influenza diagnostic tests, reverse transcription-polymerase chain reaction (RT-PCR), cell culture and others. On the basis of end-user, the global influenza diagnostic market is categorized into hospitals, point-of-care testing, and laboratories.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
Companies Profiled:
The report provides profiles of the companies in the global influenza diagnostic market such as BD Medical, Abbott laboratories, Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Sekisui Diagnostics, DiaSorin, SA Scientific and Luminex Corporation.
Report Highlights:
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global influenza diagnostic market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of influenza diagnostic market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the influenza diagnostic market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the influenza diagnostic market to understand the present and future trends in this market and formulate their strategies accordingly.
Please Choose One of them.